CMI vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 10, 2026
CMI
66.7
AI Score
VS
CMI Wins
EMR
64.6
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CMI | EMR | Winner |
|---|---|---|---|
| Revenue | 13.78B | 17.86B | CMI |
| Net Income | 1.94B | 1.65B | EMR |
| Net Margin | 14.1% | 9.2% | EMR |
| ROE | 9.5% | 12.8% | CMI |
| ROA | 4.6% | 4.6% | CMI |
| Total Assets | 42.21B | 35.63B | EMR |
| Current Ratio | 0.90 | 1.73 | CMI |
| Free Cash Flow | 2.62B | 1.37B | EMR |
Relative Price Performance (Last 90 Days)
CMI 1M: -12.7%
· 3M: -15.1%
EMR 1M: -7.1%
· 3M: +7.1%
Current Technical Phase
CMI
MarkdownSell / avoid
Price below a falling SMA50 (slope -6.6%), weak momentum, RSI 35
EMR
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
Fundamentals Snapshot
| Metric | CMI | EMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 16.5 | 21.0 |
| Trailing P/E | 28.3 | 32.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.3% | 0.5% |
| Operating Margin | 0.1% | 0.3% |
| EPS | 19.42 | 4.51 |
| Dividend Yield | 0.01% | 0.01% |
Frequently Asked Questions
Based on our detailed analysis, CMI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.